glp-1/gip peptide The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1/GIP Tirzepatide Rx | FancyMeds

Multiple studies have shown reductions in inflammatory markers among people taking GLP-1 agonists, and patients frequently report improvements in inflammation-related conditions

ColonBroom is not a pharmaceutical drug, so its effects are more subtle and dependent on consistent use

Thus, they are not publicly available to protect the data used in this study

April 29th, 2025: Lawsuit Claims Ozempic Caused Severe Vision Loss A new lawsuit has been filed outside the GLP-1 multidistrict litigation (MDL), alleging that Ozempic caused severe vision loss

The GLP-1 receptor agonists approved for weight loss include: Zepbound (tirzepatide), Saxenda (liraglutide), and Wegovy (semaglutide)

These agents should therefore be continued and/or initiated for people starting basal insulin